Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNexus Gene Lab Corp.

0.3090
-0.0010-0.32%
Volume:126.53K
Turnover:39.24K
Market Cap:5.55M
PE:-5.83
High:0.3180
Open:0.3100
Low:0.3020
Close:0.3100
Loading ...

BioNexus Gene Partners With ML Tech for Treasury Strategy

MT Newswires Live
·
08 Mar

Bionexus Gene Lab enters partnership with ML Tech

TIPRANKS
·
08 Mar

BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy

GlobeNewswire
·
08 Mar

BioNexus Gene Lab Becomes First Nasdaq-Listed Company to Embrace Ethereum as Treasury Asset

BE[IN]CRYPTO
·
06 Mar

BioNexus Stock Pops As It Embraces Ethereum-Focused Treasury Strategy, Says It Is First On Nasdaq To Do So

Benzinga
·
06 Mar

BioNexus Gene Reports Approval of Ethereum Treasury Strategy

MT Newswires Live
·
06 Mar

BRIEF-Bionexus Gene Lab Corp Announces Board Approval Of Ethereum Treasury Strategy And Release Of Strategic Whitepaper

Reuters
·
06 Mar

Bionexus Gene Lab announces board approval of Ethereum treasury strategy

TIPRANKS
·
06 Mar

BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper

THOMSON REUTERS
·
06 Mar

BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper

GlobeNewswire
·
06 Mar

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live
·
03 Jan

BioNexus Gene Lab Given Until May 1 to Regain Nasdaq Compliance; Shares Rise

MT Newswires Live
·
03 Jan

BioNexus Gene Lab Leads Our Top 3 US Penny Stocks

Simply Wall St.
·
07 Dec 2024

BioNexus Gene Lab Faces Delisting and Leadership Changes

TIPRANKS
·
09 Nov 2024

BRIEF-Bionexus Gene Lab Corp -On Nov 5, Got Notification From Nasdaq, Co To Be Delisted From Nasdaq Due To Its Failure To Comply With Listing Rule

Reuters
·
09 Nov 2024

BioNexus Gene Lab Corp -on Nov 5, Got Notification From Nasdaq, Co to Be Delisted From Nasdaq Due to Its Failure to Comply With Listing Rule

THOMSON REUTERS
·
09 Nov 2024